BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20434784)

  • 1. Risk adjustment in health insurance and its long-term effectiveness.
    Beck K; Trottmann M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):489-98. PubMed ID: 20434784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capping risk adjustment?
    Eugster P; Sennhauser M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):499-507. PubMed ID: 20462647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal cost reimbursement of health insurers to reduce risk selection.
    Kifmann M; Lorenz N
    Health Econ; 2011 May; 20(5):532-52. PubMed ID: 20572200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers.
    Kanters TA; Brouwer WB; van Vliet RC; van Baal PH; Polder JJ
    Soc Sci Med; 2013 Jan; 76(1):150-8. PubMed ID: 23182593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets.
    Paolucci F; Schut E; Beck K; Gress S; Van de Voorde C; Zmora I
    Health Econ Policy Law; 2007 Apr; 2(Pt 2):173-92. PubMed ID: 18634661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of health care utilization by German sickness fund members--with application to risk adjustment.
    Breyer F; Heineck M; Lorenz N
    Health Econ; 2003 May; 12(5):367-76. PubMed ID: 12720254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
    Stam PJ; van Vliet RC; van de Ven WP
    Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incentive-compatible guaranteed renewable health insurance premiums.
    Herring B; Pauly MV
    J Health Econ; 2006 May; 25(3):395-417. PubMed ID: 16584793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovation and risk selection in deregulated social health insurance.
    Lehmann H; Zweifel P
    J Health Econ; 2004 Sep; 23(5):997-1012. PubMed ID: 15353190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for risk-based premiums in public health insurance.
    Zweifel P; Breuer M
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):171-88. PubMed ID: 18634689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example.
    Huang IC; Dominici F; Frangakis C; Diette GB; Damberg CL; Wu AW
    Med Decis Making; 2005; 25(1):20-34. PubMed ID: 15673579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk adjustment alternatives in paying for behavioral health care under Medicaid.
    Ettner SL; Frank RG; McGuire TG; Hermann RC
    Health Serv Res; 2001 Aug; 36(4):793-811. PubMed ID: 11508640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal risk adjustment with adverse selection and spatial competition.
    Jack W
    J Health Econ; 2006 Sep; 25(5):908-26. PubMed ID: 16712986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new risk adjustment formula in Germany: implementation and first experiences.
    Buchner F; Goepffarth D; Wasem J
    Health Policy; 2013 Mar; 109(3):253-62. PubMed ID: 23276484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-insurance in the Swiss health insurance market: Fit, power, and balance.
    Schmid CP; Beck K
    Health Policy; 2016 Jul; 120(7):848-55. PubMed ID: 27157115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing risk selection incentives in health sector reforms.
    Puig-Junoy J
    Int J Health Plann Manage; 1999; 14(4):287-311. PubMed ID: 11184915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High cost pool or high cost groups-How to handle high(est) cost cases in a risk adjustment mechanism?
    Schillo S; Lux G; Wasem J; Buchner F
    Health Policy; 2016 Feb; 120(2):141-7. PubMed ID: 26806676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.